FDA Recall Open, Classified

Ambra PACS, Ambra ProViewer. Software for use as a primary diagnostic and analysis tool for diagnostic images.

Recall: Z-1818-2022 · Initiated June 23, 2022

Recall

Recall Number
Z-1818-2022
Event Number
90817
Firm
DICOM Grid, Inc. d/b/a Ambra Health
FEI Number
3008776294
Product Code
LLZ
Status
Open, Classified
Root Cause
Software design
Initiated
June 23, 2022
Posted
September 27, 2022
Address
450 Park Ave S, Fl 10-111, New York, NY, 10016-7320

Description

Ambra PACS, Ambra ProViewer. Software for use as a primary diagnostic and analysis tool for diagnostic images.

Reason

A race condition between the storage system and services database has the potential to revert edits made to patient information upon first ingestion of a study.

Action

The firm distributed an Urgent Medical Device Recall Notice dated June 23, 2022, by email to affected customers. The firm informed customers that a race condition was identified between Ambra's storage system and the serivces database which has the potential to revert edits made to patient health information upon first ingestion of a study. This could lead to a possibility that incorrect patient ifnormation is presented to the physician, which would impact the decision making in regard to patient care. Customers are asked to advise all users of the system of this issue, request a patch from Ambra to be enabled on your system, and wait until all images for a given study are ingested before manually editing patient health information in the study. Ambra's actions include the deployment of a patch that is acting as a temporary fix until a software update can be deployed to all customers, which will prevent the issue from occurring in the future.

Distribution

Domestic: AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, DC, & PR.

Quantity

671 downloads